SMYD3 links lysine methylation of MAP3K2 to Ras-driven cancer
2014 · Nature · 405 citations
https://doi.org/10.1038/nature13320
P
Paweł K. Mazur
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
173
Papers
5.6K
Citations
34
h-index
48
i10-index
Paweł K. Mazur is an academic researcher from The University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Epigenetics and DNA Methylation & Lung Cancer Research Studies & RNA modifications and cancer. The author has an h-index of 34, co-authored 148 publications.
ORCID: 0000-0002-5820-8344Papers by this author
worksA Meta-analysis of Lung Cancer Gene Expression Identifies <i>PTK7</i> as a Survival Gene in Lung Adenocarcinoma
2014 · Cancer Research · 158 citations
https://doi.org/10.1158/0008-5472.can-13-2775
SMYD5 methylation of rpL40 links ribosomal output to gastric cancer
2024 · Nature · 34 citations
https://doi.org/10.1038/s41586-024-07718-0
Expression and Clinicopathological Significance of Notch Signaling and Cell-Fate Genes in Biliary Tract Cancer
2011 · The American Journal of Gastroenterology · 29 citations
https://doi.org/10.1038/ajg.2011.305
SMYD3 Impedes Small Cell Lung Cancer Sensitivity to Alkylation Damage through RNF113A Methylation–Phosphorylation Cross-talk
2022 · Cancer Discovery · 29 citations
https://doi.org/10.1158/2159-8290.cd-21-0205
SMYD5 is a ribosomal methyltransferase that catalyzes RPL40 lysine methylation to enhance translation output and promote hepatocellular carcinoma
2024 · Cell Research · 14 citations
https://doi.org/10.1038/s41422-024-01013-3
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat